Working together for Progress in Hair Research.
Behind 8T3 stands an interdisciplinary team from research, development, and clinical practice. We share one goal: to harness the power of CD83 for a new era of hair regeneration – evidence-based, responsible, and innovative.
Pioneers of a new class of active ingredients.
With their many years of research on CD83, they paved the way for what is now used under the name 8T3: soluble CD83 (sCD83) – a molecule with an impressive effect on hair growth and hair follicle health. Mallia has developed its own animal-free form of this molecule: MAL-838 – the core component of 8T3.
Prof. Dr. Alexander Steinkasserer
Dr. Manfred Groeppel
Dr. Anne Asmuß
This is how we work.
From molecular research to clinical application: At Mallia Therapeutics, we develop novel active agents that specifically activate biological processes in the hair follicle. At the center of this is the molecule CD83 – an immunomodulatory substance whose regenerative effect we are the first to make accessible for cosmetic-therapeutic use in the hair field. Our work combines state-of-the-art laboratory technology, many years of immunological expertise, and a clear commitment to evidence and efficacy.
How we conduct research – our principle.
Our work is based on clear principles – not only in the laboratory, but also in our thinking. For us, research means breaking new ground without blind activism. It means using technology without ethical shortcuts. And it means creating proximity – between science and application, between molecules and people.
Think scientifically
We work based on evidence – from the first cell to the final formulation.
Take responsibility
Our form of sCD83 is produced without animal testing. We rely on safe, transparent processes.
Create closeness
Our research is practical: oriented toward everyday life, inspired by real needs – for solutions that provide measurable help.
